Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5026
ARK Israel Innovative Technology ETF
IZRL
$132M
| $1.16M | ﹤0.01% |
38,221
+995
| +3% | +$29.8K |
2019 Q4
26 quarters
|
|
5027
Eagle Financial Services Inc
EFSI
$248M
| $1.16M | ﹤0.01% |
27,997
-84
| -0.3% | -$3.29K |
2025 Q1
5 quarters
|
|
5028
DELISTED
Olaplex Holdings
OLPX
| $1.16M | ﹤0.01% |
565,581
+202,781
| +56% | +$413K |
2021 Q3
19 quarters
|
|
5029
FreightCar America
RAIL
$197M
| $1.16M | ﹤0.01% |
118,844
-82,440
| -41% | -$694K |
2013 Q3
51 quarters
|
|
5030
Ranpak Holdings
PACK
$296M
| $1.16M | ﹤0.01% |
158,243
+28,063
| +22% | +$162K |
2019 Q2
28 quarters
|
|
5031
Bank7 Corp
BSVN
$558M
| $1.16M | ﹤0.01% |
23,611
-10,768
| -31% | -$475K |
2018 Q3
31 quarters
|
|
5032
Vanguard Total Corporate Bond ETF
VTC
$1.64B
| $1.15M | ﹤0.01% |
15,007
-26
| -0.2% | -$2K |
2020 Q3
23 quarters
|
|
5033
Net Lease Office Properties
NLOP
$146M
| $1.15M | ﹤0.01% |
103,308
-2,538
| -2% | -$30.6K |
2023 Q4
10 quarters
|
|
5034
Tradr 2X Long AXTI Daily ETF
AXTX
$281M
| $1.15M | ﹤0.01% |
+19,717
| New | +$2.94M |
2026 Q2
0 quarters
|
|
5035
Elevra Lithium Ltd
ELVR
$541M
| $1.15M | ﹤0.01% |
16,852
-5,879
| -26% | -$474K |
2025 Q3
3 quarters
|
|
5036
AdvisorShares Insider Advantage ETF
SURE
$57.8M
| $1.15M | ﹤0.01% |
7,708
| – | – |
2013 Q4
50 quarters
|
|
5037
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.53B
| $1.15M | ﹤0.01% |
28,970
-1,429
| -5% | -$63.6K |
2020 Q2
24 quarters
|
|
5038
Goldman Sachs Innovate Equity ETF
GINN
$187M
| $1.14M | ﹤0.01% |
14,492
+1,226
| +9% | +$93.1K |
2020 Q4
22 quarters
|
|
5039
Dingdong
DDL
$466M
| $1.14M | ﹤0.01% |
591,411
+34,921
| +6% | +$86.7K |
2021 Q4
18 quarters
|
|
5040
American Resources Corp
AREC
$123M
| $1.14M | ﹤0.01% |
530,065
-107,989
| -17% | -$241K |
2021 Q1
21 quarters
|
|
5041
Vor Biopharma
VOR
$1.09B
| $1.13M | ﹤0.01% |
61,561
-55,160
| -47% | -$835K |
2021 Q2
20 quarters
|
|
5042
Columbia Research Enhanced International Equity ETF
REFA
$6.87M
| $1.13M | ﹤0.01% |
50,000
| – | – |
2025 Q4
2 quarters
|
|
5043
Simplify MBS ETF
MTBA
$1.02B
| $1.13M | ﹤0.01% |
23,046
+274
| +1% | +$13.5K |
2023 Q4
10 quarters
|
|
5044
Starz Entertainment Corp
STRZ
$433M
| $1.13M | ﹤0.01% |
39,184
-18,809
| -32% | -$410K |
2025 Q2
4 quarters
|
|
5045
Immuneering
IMRX
$234M
| $1.13M | ﹤0.01% |
226,491
-69,576
| -24% | -$352K |
2021 Q3
19 quarters
|
|
|
EROC
5046
ERock Inc
EROC
$459M
| $1.13M | ﹤0.01% |
+77,931
| New | +$1.24M |
2026 Q2
0 quarters
|
|
5047
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
| $1.13M | ﹤0.01% |
37,682
+11,063
| +42% | +$314K |
2015 Q2
44 quarters
|
|
5048
Aviat Networks
AVNW
$251M
| $1.13M | ﹤0.01% |
50,677
-29,971
| -37% | -$587K |
2013 Q2
52 quarters
|
|
5049
Firy Inc
FIRY
$191M
| $1.12M | ﹤0.01% |
110,121
+81,510
| +285% | +$567K |
2020 Q3
23 quarters
|
|
5050
Conduent
CNDT
$230M
| $1.12M | ﹤0.01% |
766,922
-491,857
| -39% | -$764K |
2017 Q1
37 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.